Impact of monopolar radiofrequency coagulation on intraoperative blood loss during liver resection: a prospective randomised controlled trial by Quesada-Diez, Rita et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=ihyt20
Download by: [81.202.167.35] Date: 14 February 2017, At: 21:50
International Journal of Hyperthermia
ISSN: 0265-6736 (Print) 1464-5157 (Online) Journal homepage: http://www.tandfonline.com/loi/ihyt20
Impact of monopolar radiofrequency coagulation
on intraoperative blood loss during liver resection:
a prospective randomised controlled trial
Rita Quesada, Ignasi Poves, Enrique Berjano, Carles Vilaplana, Anna
Andaluz, Xavier Moll, Dimitri Dorcaratto, Luis Grande & Fernando Burdio
To cite this article: Rita Quesada, Ignasi Poves, Enrique Berjano, Carles Vilaplana, Anna
Andaluz, Xavier Moll, Dimitri Dorcaratto, Luis Grande & Fernando Burdio (2017) Impact of
monopolar radiofrequency coagulation on intraoperative blood loss during liver resection: a
prospective randomised controlled trial, International Journal of Hyperthermia, 33:2, 135-141, DOI:
10.1080/02656736.2016.1231938
To link to this article:  http://dx.doi.org/10.1080/02656736.2016.1231938
© 2016 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
Accepted author version posted online: 16
Sep 2016.
Published online: 05 Oct 2016.
Submit your article to this journal Article views: 139
View related articles View Crossmark data
ORIGINAL ARTICLE
Impact of monopolar radiofrequency coagulation on intraoperative blood loss
during liver resection: a prospective randomised controlled trial
Rita Quesadaa,b, Ignasi Povesc, Enrique Berjanod, Carles Vilaplanae, Anna Andaluzf, Xavier Mollf,
Dimitri Dorcarattog, Luis Grandec and Fernando Burdioc
aCancer Research Group HBP, Fundacion Instituto Mar de Investigaciones Medicas, Barcelona, Spain; bApeiron Medical, Valencia, Spain;
cGeneral Surgery Department, Hospital del Mar, Barcelona, Spain; dDepartment of Electronic Engineering, Universitat Politecnica de Valencia,
Valencia, Spain; eClinical Chemistry, Laboratori de Referencia de Catalunya, Hospital del Mar, Barcelona, Spain; fMedicine and Surgery of
Animals Department, Facultat de Veterinaria, Universitat Autonoma de Barcelona, Bellaterra, Spain; gHepatobiliary and Liver Transplant
Surgical Unit, St. Vincent's University Hospital, Dublin, Ireland
ABSTRACT
Purpose: To evaluate the impact of using monopolar thermal coagulation based on radiofrequency
(RF) currents on intraoperative blood loss during liver resection.
Materials and methods: A prospective randomised controlled trial was planned. Patients undergoing
hepatectomy were randomised into two groups. In the control group (n¼ 10), hemostasis was
obtained with a combination of stitches, vessel-sealing bipolar RF systems, sutures or clips. In the
monopolar radiofrequency coagulation (MRFC) group (n¼ 18), hemostasis was mainly obtained using
an internally cooled monopolar RF electrode.
Results: No differences in demographic or clinical characteristics were found between groups. Mean
blood loss during liver resection in the control group was more than twice that of the MRFC group
(556±471ml vs. 225±313ml, p¼ .02). The adjusted mean bleeding/transection area was also signifi-
cantly higher in the control group (7.0± 3.3ml/cm2 vs. 2.8± 4.0ml/cm2, p¼ .006). No significant differ-
ences were observed in the rate of complications between the groups.
Conclusions: The findings suggest that the monopolar electrocoagulation created with an internally
cooled RF electrode considerably reduces intraoperative blood loss during liver resection.
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Intraoperative blood loss and perioperative transfusion
increases mortality and morbidity and reduces long-term sur-
vival after hepatic resection in liver tumours [1,2]. Several
methods of minimising intraoperative blood loss are currently
available for hepatic resection, specifically during parenchy-
mal transection [3]. The most important resection techniques
generally used today are finger fracture or the crush/clamp
technique, Cavitron Ultrasonic Surgical Aspirator (CUSA,
Cavitron, Stamford, CT), water-jet technology, stapler, and
monopolar and bipolar electrosurgical electrodes [4–7].
Different sealing devices such as harmonic scalpels, ultra-
sound scissors, radiofrequency-based monopolar and bipolar
vessel-sealing systems have recently gained importance in
liver surgery [8–12]. Due to these continuous improvements
in medical technology and post-operative care, reported peri-
operative mortality has dropped to 5% and morbidity rates
vary between 20–40% [6]. However, the optimal transection
technique has still not been found and using different
energy-based devices for different steps of the operation is
also cumbersome in terms of the flow procedure and a cer-
tain degree of skill is required for their proper use [9].
During surgical liver resection, the major amount of blood
is lost during the parenchyma transection stage and during
the final checking of the resection surface [13]. The strategy
based on pre-coagulating the parenchyma using radiofre-
quency (RF) energy by creating thick coagulation zones
before division is interesting, since it allows vessels to be
coagulated when they are still enclosed by tissue. This is
obviously less complicated than managing bleeding caused
by a vessel in the same transection plane. In any case, the
underlying idea is always the same: vessels located in the
coagulation zone are sealed due to the thermal denaturation
of the collagen present on their walls and the flow of blood
is subsequently stopped.
The idea of pre-coagulating tissue with RF energy before
division was initially conducted with needle electrode arrays
to allow small vessels to be sealed and subsequently dividing
by surgical scalpel, theoretically without bleeding [13]. It is
also possible to create these coagulation zones prior to the
division by using pencil-type RF electrodes working in
monopolar soft coagulation mode (as illustrated in
Figure 1A), i.e. delivering high-power current (up to 2 A)
through a good contact between electrode and tissue, and
using a relatively low voltage (< 200 V). The principal
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drawback of the needle electrodes is that large vessels are
often incompletely collapsed, which results in blood loss
when transection is conducted, necessitating tedious suturing
and additional clipping tasks [13]. In contrast, pencil-type RF
electrodes would allow surgeons to clearly identify bleeding
points in the same transection plane caused by medium and
large vessels and to manage them by creating a new deep
coagulation zone as illustrated in Figure 1(B). Finally, once
the division has been accomplished, final applications of RF
energy on the remaining resection surface would create new
coagulation zones with preventive purposes to avoid late
bleeding (Figure 1C) and even enlarge resection margins to
minimise local hepatic recurrence [14–16].
We hypothesised that the creation of all these coagulation
zones throughout liver resection (prior to the division to
coagulate vessels located in zone to be transected, at the
bleeding points on the transection surface during the div-
ision, and finally on the remaining resection surface) using a
pencil-like RF electrode in monopolar soft coagulation mode
would minimise intraoperative blood loss. We planned a pro-




From July 2010 to February 2014, all the patients who under-
went partial hepatectomy at the Hospital del Mar (Barcelona,
Spain) were considered for inclusion in the study. The inclu-
sion criteria were colorectal liver metastases to be resected
by any type of hepatectomy and American Anaesthesia
Association (ASA) ranging from I to III via open or laparo-
scopic surgery. With these criteria, 28 patients were enrolled
in the study, and were randomly allocated to the control
group or the monopolar RF coagulation (MRFC) group. The
allocation schedule was generated by computer-generated
random numbers, with an allocation ratio of 1:2 of assign-
ment to each group (Figure 1). All the patients signed an
informed consent form before surgery, and underwent a
careful pre-operative assessment of their disease, including
spiral computed tomography or magnetic resonance imag-
ing, and showed no evidence of unresectable extrahepatic
disease. The study was approved by the local ethical commit-
tee and by the Spanish Agency of Medicines and Medical
Devices (AEMPS) and was registered and audited as a
randomised-clinical trial (AGEMED 312/08 EC) according to
the European Directive for Clinical Trials with Medical Devices
(Directive 93/42/EEC).
Surgical procedure
All the procedures were performed by the same surgeons
(FB and IP). For open surgery, the procedure was similar to
that described in [17]. For laparoscopic surgery, after the
pneumoperitoneum was established and exposure obtained,
laparoscopic ultrasound was used to identify the tumour. In
both groups, the dissection was carried out with standard
devices such as ultrasonic dissectors, bipolar forceps and
Ligasure device (Valleylab, Boulder, CO). Hemostasis was
obtained in the control group with a combination of stitches,
bipolar forceps and Ligasure (Medtronic, Minneapolis, MN),
including sutures or clips. In contrast, hemostasis in the
MRFC group was mainly obtained with the Coolinside device
(Apeiron Medical, Valencia, Spain) which has shown a short
learning curve [17]. This device works in coagulation soft
mode, delivering RF power through an internally cooled elec-
trode, and creating large coagulation zones 6 9mm in
depth [18,19]. Additionally, it has a built-in blade which
allows cutting the previously coagulated tissue, and thus
avoids the need for an additional dissecting device. In the
laparoscopic approach, the Coolinside device was introduced
through a 12-mm trocar.
Note that although the Ligasure device (which is really an
RF-based device) was employed at some point in the proced-
ure in both groups, essentially in hepatectomies next to large
vessels, the creation of RF-induced deep coagulation zones
was exclusively limited to the MRFC group, as bipolar devices
(as Ligasure) exhibit a significantly smaller thermal spread
(i.e. coagulation depth) [20].
Outcome measures
The outcomes were: 1) transection time: total transection
time, including time for achieving complete hemostasis; 2)
blood loss: total blood loss during transection (from suction
device and blood-soaked gauzes); 3) transection area:
obtained by delineation of the transection plane (digitally
photographed) using 3D Doctor software (Able Software
Corp., Lexington, MA); 4) transection speed: the ratio of tran-
section area to transection time; 5) blood loss per transection
Figure 1. Creation of large coagulation zones using monopolar thermal coagulation could minimise intraoperative blood loss throughout different stages of liver
resection: initial coagulation of the vessels located in zone to be transected (A), coagulation of vessels on the margin of resection during the transection (B), and
preventive coagulation of the remaining resection surface (C).
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area; and 6) the complications described in [17]. Additionally,
the biochemical analysis of ferritin, iron and transferrin
was measured in urine previously and immediately after
transection to check its association with the hepatic coagula-
tive necrosis of the transection margin, given that a consider-
able amount of the body’s ferritin is stored in the
hepatocytes [21].
Statistical analysis
The sample size of the study in each group was calculated
by means of the formula proposed by Lehr [22]: N¼ 16/
SMD2, where SMD is the standardised mean difference
between the two means being compared. The difference
between groups was calculated from the mean blood loss
per transection area for each group [17,23] and the minimum
sample size per group was N¼ 9. All the statistical tests were
two-sided and a p values <.05 was considered to indicate
statistical power. The analysis was performed on SPSS
Statistics software (SPSS Inc., Chicago, IL). Data are given as
the mean± standard deviation or by a confidence interval,
while complications are described.
Results
During the study period, 110 patients were assessed for eligi-
bility for this study. Eighty-two patients were subjected to
liver resection but were excluded for the following reasons:
primary liver tumours (n¼ 54), cyst tumour (n¼ 16) and
others (n¼ 12). No patients refused to take part in the study.
Twenty-eight patients suffering from hepatic metastases
underwent hepatic resection and were randomly allocated to
either the control (n¼ 10) or the MRFC group (n¼ 18)
(Figure 2). No primary disease of the liver was observed in
any patient. There were no deviations, no crossovers or
withdrawals after randomisation. Table 1 summarises the
baseline and operative characteristics. No statistically signifi-
cant difference was noted between the groups regarding
pre- and intra-operative patient characteristics.
No differences were observed either in the weight of the
surgical specimen or in the mean area of the transection
between the control and MRFC groups, respectively. The use
of temporary vascular occlusion (Pringle manoeuvre) was
similar in both groups (40 and 38%, respectively) but, when
required, its duration in the control group was more than
double that of the MRFC group (Table 1).
No significant differences were observed either in transec-
tion time (77.7 ± 38.9min and 64.2 ± 44.5min) or in median
transection speed (1.3 ± 1.2 cm2/min and 1.4 ± 0.7 cm2/min)
for the control and the MRFC group, respectively. However,
mean blood loss during liver resection in the control group
was more than twice that of the MRFC group (556 ± 471ml
and 225 ± 313ml, respectively, p¼ .021). The differences
between the groups were also greater when considering the
adjusted variable of the blood loss (mean blood loss per
transection area): 7.0 ± 3.3ml/cm2 vs. 2.8 ± 4.0ml/cm2 for
the control and the MRFC group, respectively (p¼ .006)
(Figure 3).
As shown in Table 2, no differences were observed in the
rate of complications between the groups, nor were there
significant differences in mortality and morbidity. The only
exitus took place in the MRFC group because of several post-
operative complications associated with a combined non-
hepatic procedure (related to intestinal reconstruction). Four
patients subjected to major hepatectomies in the MRFC
group required blood transfusions (see Table 3 for details).
Finally, no significant differences were observed in either fer-
ritin, iron or transferrin urine levels between the groups,
though a post-transection increase in ferritin was observed in
many cases in the MRFC group (Table 4).
Figure 2. CONSORT (Consolidated Standards of Reporting Trials) diagram for this study.
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Discussion
Intra-operative blood loss and peri-operative transfusion not
only increase the risk of surgical morbidity and mortality
[1,2,24] but also jeopardise long-term survival because they
actually increase the recurrence rate of the tumour being
resected [24,25]. One of the goals in liver operations is there-
fore to reduce blood loss, and several RF-assisted devices
have been developed for this purpose. Our hypothesis was
that the creation of large coagulation zones in different
stages of the liver resection could reduce intraoperative
blood loss. Our findings confirmed that there was a reduction
from 556± 471ml to 225± 312ml and these differences were
even greater when we took into account the adjusted vari-
able (7.0 ± 3.3ml/cm2 vs. 2.8 ± 4.0ml/cm2). These values are in
agreement with the previously reported experience using the
Coolinside device [17–19], and with reported median values
from other specialised institutions (ranging from 155ml to
more than 750ml) [1,9,26–29]. Importantly, the blood loss in
our MRFC group was relatively close to the value reported in
a clinical study (355ml) in which monopolar RF coagulation
was conducted using TissueLink (Medtronic, Minneapolis,
MN) combined with a CUSA device [8].
Overall, our results are comparable or even better than
current published data from leading liver units. Furthermore,
these differences are greater when the adjusted blood loss is
evaluated in the transection area (7.0 ± 3.3ml/cm2 vs.
2.8 ± 4.0ml/cm2 for control and MRFC groups, respectively,
see Figure 2). This compares favourably with other leading
Table 1. Demographic and clinical characteristics of the patients involved in the study.
Total Control group (n¼ 10) MRFC group (n¼ 18) p
Age (years) 64.4 ± 11.1 64.6 ± 13.3 64.3 ± 12.6 n.s.
Sex (male/female) 17/11 6/4 11/7 n.s.
Laparoscopy approach 46% 6 (60%) 7 (39%) n.s.
Nodules/patient 1.7 ± 1.3 1.9 ± 1.6 1.6 ± 1.2 n.s.
Size of the largest nodule (cm) 3.5 3.3 3.9 n.s.
Combined colorectal surgery 4 (14%) 1 (10%) 3 (17%) n.s.
Major hepatectomy (> 3 segments) 9 (32%) 2 (20%) 7 (39%) n.s.
Weight of the surgical specimen (g) 283 ± 334 338 ± 359 257 ± 328 n.s.
Area of transection (cm2) 83 ± 62 79 ± 61 86 ± 64 n.s.
Positive margin 10 (42%) 2 (25%) 8 (44%) n.s.
Pringle manoeuvre (min) 21 ± 19 33 ± 25 15 ± 10 n.s.
Charlson index 10.8 ± 0.2 11.1 ± 0.4 10.6 ± 0.3 n.s.
Data represents the mean ± SD or the number of patients. Values in brackets are percentages.Differences in variable were considered to be significant at a threshold of p< .05 (n.s.: not statistically significant).
Figure 3. Box plots depicting blood loss during the transection (A) and blood loss per transection area (B) for control and monopolar RF coagulation (MRFC)
groups. The boxes represent the interquartile range which contains 50% of the values. The whiskers are lines that extend from the box to the highest and lowest
values, excluding outliers. The line across the box indicates the median. Both outcomes were statistically significant (p< .05).





group (n¼ 18) p
Mortality 1 (4%) 0 (0%) 1 (5%) n.s.
Morbidity 9 (32%) 3 (30%) 6 (33%) n.s.
Abscess 7 (25%) 3 (30%) 4 (22%) n.s.
Biliary leak 3 (11%) 0 (0%) 3 (17%) n.s.
Hemoperitoneum 1 (4%) 0 (0%) 1 (5%) n.s.
Liver failure 0 (0%) 0 (0%) 0 (0%) n.s.
Wound infection 2 (7%) 0 (0%) 2 (11%) n.s.
Pneumonia 0 (0%) 0 (0%) 0 (0%) n.s.
Other complications 6 (21%) 2 (20%) 4 (22%) n.s.
Blood transfusion 4 (14%) 0 (0%) 4 (22%) n.s.
Values in brackets are percentages.Differences in variable were considered to be significant at a threshold of p< .05 (n.s.: not statistically significant).
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techniques, such as the water jet (10.6 ± 15.3ml/cm2) [7] and
even other RF-assisted devices (5.5ml/cm2) [29]. In compari-
son with other RF electrodes for monopolar coagulation
(such as TissueLink) [8], it must be acknowledged that the
Coolinside device does not speed up the transection, though
it is no slower than others in either the open or laparoscopic
approaches.
Both groups showed similar rates of post-operative mor-
bidity (30%), comparable to other published studies
[8,30,31]. As detailed in Table 3, the patients that required
blood transfusions in the MRFC group possessed risk factors
that could have played a role in the decision to transfuse,
but the transfusion was not a direct consequence of blood
loss. These results are also comparable to currently published
data from leading liver units [1,8,9,26–28].
Although there were no significant differences, the bio-
chemical findings suggest that the creation of large thermal
coagulation zones could be associated with an occasional
increase in the urine levels of ferritin, iron and transferrin
after the hepatic procedure (Table 4). As it is known that
most ferritin is stored in the parenchyma of the hepatocytes
[20], the temporary elevation of urinary ferritin after transec-
tion could be associated with the thick band of
coagulated tissue in the transaction margin of the MRFC
group (Figure 4).
Some limitations of this study must be pointed out. First,
the sample size, even though small, was specifically designed
to show up differences in the adjusted blood loss according
to previous clinical results [17]. In fact, we found that this
sample was big enough to point out significant differences
between the groups. Second, some authors have suggested
that the use of RF-assisted transection devices may facilitate
abscess formation, biliary leakage or damage to vessels or
main hepatic ducts. In this respect, we did not find signifi-
cant differences between the groups which could be linked
directly to the device used (Table 2). This use of the RF elec-
trode to create large thermal coagulation zones was associ-
ated with similar rates of post-operative morbidity (30%)
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Table 4. Biochemical levels of ferritin, iron and transferrin in urine previously and after the surgical transection.
Control group (n¼ 10)
Monopolar RF coagulation group
(n¼ 18)
Pre-transection Post-transection p Pre-transection Post-transection p
Ferritin (ng/ml) 10.0 ± 7.4 13.0 ± 11.6 n.s. 27.5 ± 31.9 242.2 ± 559.1 n.s.
FE (mcg/dl) 5.0 ± 0 5.0 ± 0 n.s. 5.0 ± 0 5.9 ± 2.8 n.s.
Transferrin (mg/dl) 10.0 ± 0 10.0 ± 0 n.s. 10.0 ± 0 11.3 ± 4.7 n.s.
Data represents the mean ± SD.Differences in variable were considered to be significant at a threshold of p< .05 (n.s.: not statistically significant).
Figure 4. Examples of RF-induced large coagulation zones in the monopolar RF coagulation (MRFC) group. (A) Limited resection in which the monopolar electrode
with built-in blade was used as sole sealing and dissecting device. (B) Segmentectomy of segments 5–8, 4a, and two limited resections. Note the thickness of the
coagulation zones created on the resection surfaces, which were possibly responsible for the minimal intraoperative bleeding in the MRFC group.
INTERNATIONAL JOURNAL OF HYPERTHERMIA 139
as the conventional techniques used with the control group
and other published studies [8,30,31]. This large coagulation
did not impede correct evaluation of the margin either. As
detailed in Table 3, the patients in the MRFC group that
required blood transfusion presented risk factors that com-
promised the transfusion, but the transfusion was not a dir-
ect consequence of blood loss during transection. Third,
although the results about positive margin and local recur-
rence in the MRFC group suggest that the coagulation zones
created with RF could be treating residual tumour at the
margin, the numbers are still too small to obtain solid con-
clusions, and hence this issue warrants further evaluation.
Fourth, the cost of both techniques was not evaluated in this
study.
In conclusion, the creation of extensive coagulation zones
using a monopolar RF electrode during different stages of
liver resection (in both the open and laparoscopic
approaches) reduces intraoperative blood loss.
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